April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Central Vision After Treatment of Ciliochoroidal Melanoma With Iodine-125 Brachytherapy
I. Tsui; T. A. McCannel; S. C. N. Oliver; M. W. Chun; L. H. Kobe; M. Y. Leu; S. P. Lee; F. Yu; T. Nulliah; B. R. Straatsma
Author Affiliations & Notes
  • I. Tsui
    Ophthalmology,
    University of California, Los Angeles, Los Angeles, California
  • T. A. McCannel
    Ophthalmology,
    University of California, Los Angeles, Los Angeles, California
  • S. C. N. Oliver
    Ophthalmology, University of Colorado, Denver, Colorado
  • M. W. Chun
    Ophthalmology,
    University of California, Los Angeles, Los Angeles, California
  • L. H. Kobe
    Radiation Oncology,
    University of California, Los Angeles, Los Angeles, California
  • M. Y. Leu
    Radiation Oncology,
    University of California, Los Angeles, Los Angeles, California
  • S. P. Lee
    Radiation Oncology,
    University of California, Los Angeles, Los Angeles, California
  • F. Yu
    Ophthalmology,
    University of California, Los Angeles, Los Angeles, California
  • T. Nulliah
    Ophthalmology,
    University of California, Los Angeles, Los Angeles, California
  • B. R. Straatsma
    Ophthalmology,
    University of California, Los Angeles, Los Angeles, California
  • Footnotes
    Commercial Relationships  I. Tsui, None; T.A. McCannel, None; S.C.N. Oliver, None; M.W. Chun, None; L.H. Kobe, None; M.Y. Leu, None; S.P. Lee, None; F. Yu, None; T. Nulliah, None; B.R. Straatsma, None.
  • Footnotes
    Support  IT is a Harold and Pauline Price Fellow.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 5705. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Central Vision After Treatment of Ciliochoroidal Melanoma With Iodine-125 Brachytherapy
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      I. Tsui, T. A. McCannel, S. C. N. Oliver, M. W. Chun, L. H. Kobe, M. Y. Leu, S. P. Lee, F. Yu, T. Nulliah, B. R. Straatsma; Central Vision After Treatment of Ciliochoroidal Melanoma With Iodine-125 Brachytherapy. Invest. Ophthalmol. Vis. Sci. 2009;50(13):5705.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : To report best-corrected visual acuity, contrast sensitivity and color vision in patients with ciliochoroidal melanoma prior to, six months after and one year after treatment with Iodine-125 brachytherapy.

Methods: : Prospective single center cohort study of best-corrected visual acuity, contrast sensitivity and color vision in 40 patients (40 eyes) with medium-sized ciliochoroidal melanoma treated with Iodine-125 brachytherapy at a dose of 8,500 rads to the tumor apex. Best-corrected visual acuity assessed after COMS protocol refraction using the ETDRS chart, Pelli-Robinson contrast sensitivity and HRR color vision were assessed within one month prior to, six months after and one year after brachytherapy. Melanoma dimensions were assessed by ultrasonography at the same intervals.

Results: : 40 patients (40 eyes) had a mean age of 58 years (range 30-78 years). Prior to, six months after and one year after brachytherapy, mean best-corrected visual acuity was 47 (20/30), 40 (20/50), 38 (20/63) ETDRS letters respectively; mean Pelli-Robinson contrast sensitivity was 30 (4.4%), 26 (6.2%), 26 (6.2%) letters; mean HRR color vision was 13/14, 10,/14 10/14. Visual acuity and contrast sensitivity at six months and one year were inversely correlated to baseline tumor height.

Conclusions: : This prospective study evaluated best-corrected ETDRS visual acuity, contrast sensitivity, and color vision after brachytherapy for ciliochoroidal melanoma. Following brachytherapy, eyes treated showed a statistically significant change in visual function; central visual function at six months and one year was inversely related to baseline tumor height.

Keywords: melanoma • choroid • tumors 
© 2009, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept